目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 31)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 SEGMENTS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 36)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 CELL ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE)
FIGURE 4 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE SHARE ANALYSIS, 2022
FIGURE 5 AVERAGE MARKET SIZE ESTIMATION (2022)
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 6 CELL ANALYSIS INDUSTRY: CAGR PROJECTIONS (2023-2028)
FIGURE 7 MARKET: ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 INSIGHTS FROM PRIMARIES
FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS
2.6 RESEARCH ASSUMPTIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 46)
FIGURE 10 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 CELL ANALYSIS INDUSTRY, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MARKET, BY PROCESS, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 51)
4.1 CELL ANALYSIS MARKET OVERVIEW
FIGURE 15 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET
4.2 NORTH AMERICA: MARKET SHARE, BY PRODUCT & SERVICE (2022)
FIGURE 16 REAGENTS & CONSUMABLES SEGMENT HELD LARGEST MARKET SHARE IN 2022
4.3 NORTH AMERICA: MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
FIGURE 17 FLOW CYTOMETRY SEGMENT TO DOMINATE NORTH AMERICAN MARKET IN 2028

5 MARKET OVERVIEW (Page No. - 54)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 CELL ANALYSIS INDUSTRY: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing preference for cell-based assays in drug discovery
5.2.1.2 Increasing funding for cell-based research
TABLE 2 NIH FUNDING FOR CELL-BASED RESEARCH, 2019-2021 (USD MILLION)
5.2.1.3 Rising number of drug discovery activities
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments and restrictions on reagent use
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of single-cell sequencing
5.2.3.2 Application scope of novel cell-based assays in cancer research
5.2.4 CHALLENGES
5.2.4.1 Standardization of protocols and data integration & quality control for developing cell therapies
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF BUYERS
5.3.4 BARGAINING POWER OF SUPPLIERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 VALUE CHAIN ANALYSIS
FIGURE 19 MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 20 MARKET: ECOSYSTEM ANALYSIS
5.6 REGULATORY ANALYSIS (FLOW CYTOMETRY-BASED CELL ANALYSIS)
5.6.1 STRINGENT FDA REQUIREMENTS
5.6.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE
5.6.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
5.6.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
5.6.5 GREATER GLOBAL RECOGNITION FOR IVD CE MARK APPROVALS
5.6.6 US REIMBURSEMENT SCENARIO
5.7 TECHNOLOGY ANALYSIS
FIGURE 21 TECHNOLOGY ANALYSIS: MARKET
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 22 MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
5.9.2 MARKET: BUYING CRITERIA
FIGURE 23 KEY BUYING CRITERIA OF CELL ANALYSIS PRODUCTS
5.10 KEY CONFERENCES AND EVENTS, 2023-2024
TABLE 4 CELL ANALYSIS CONFERENCES (2023-2024)
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES
TABLE 5 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES (TOP 5 KEY PLAYERS)*
5.11.2 AVERAGE SELLING PRICE TREND

6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE (Page No. - 71)
6.1 INTRODUCTION
TABLE 6 CELL ANALYSIS INDUSTRY, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
6.2 REAGENTS & CONSUMABLES
6.2.1 DEVELOPMENT OF NOVEL CELL ANALYSIS KITS & REAGENTS FOR FLOW CYTOMETRY TO BOOST GROWTH
TABLE 7 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 8 NORTH AMERICA: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 9 EUROPE: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 INNOVATIONS IN CELL ANALYSIS INSTRUMENTS FOR DRUG DISCOVERY TO DRIVE MARKET
TABLE 11 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 12 NORTH AMERICA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 13 EUROPE: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
6.4 ACCESSORIES
6.4.1 USE OF ACCESSORIES TO CUSTOMIZE FLOW CYTOMETRY INSTRUMENTS TO BOOST SEGMENT GROWTH
TABLE 15 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 16 NORTH AMERICA: MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 17 EUROPE: MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC: MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
6.5 SOFTWARE
6.5.1 EXPANDING POOL OF KEY PLAYERS INTRODUCING UNIQUE DATA INTERPRETATION SOFTWARE TO DRIVE SEGMENT
TABLE 19 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 20 NORTH AMERICA: MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 21 EUROPE: MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
6.6 SERVICES
6.6.1 WORKFLOW CONTINUITY AND HIGH-PERFORMANCE ATTRIBUTES TO BOOST DEMAND FOR REMOTE SERVICES
TABLE 23 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 24 NORTH AMERICA: MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 25 EUROPE: MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC: MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)

7 CELL ANALYSIS MARKET, BY TECHNIQUE (Page No. - 86)
7.1 INTRODUCTION
TABLE 27 CELL ANALYSIS INDUSTRY, BY TECHNIQUE, 2021-2028 (USD MILLION)
7.2 FLOW CYTOMETRY
7.2.1 ABILITY TO PERFORM MULTIPLE MEASUREMENTS ON SINGLE CELLS TO DRIVE SEGMENT
TABLE 28 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 29 NORTH AMERICA: MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 30 EUROPE: MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 31 ASIA PACIFIC: MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
7.3 PCR
7.3.1 EFFECTIVE MEASUREMENT AND RARE SEQUENCE MONITORING BENEFITS TO DRIVE DIGITAL PCR DEMAND
TABLE 32 MARKET FOR PCR, BY REGION, 2021-2028 (USD MILLION)
TABLE 33 NORTH AMERICA: MARKET FOR PCR, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 34 EUROPE: MARKET FOR PCR, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: MARKET FOR PCR, BY COUNTRY, 2021-2028 (USD MILLION)
7.4 CELL MICROARRAYS
7.4.1 HIGH EXPERIMENTAL THROUGHPUT OF CELL MICROARRAYS OVER TRADITIONAL METHODS TO DRIVE SEGMENT
TABLE 36 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 37 NORTH AMERICA: MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 38 EUROPE: MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 39 ASIA PACIFIC: MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
7.5 MICROSCOPY
7.5.1 RISING INCIDENCE OF CANCER AND GROWING INVESTMENTS IN CELL BIOLOGY TO DRIVE SEGMENT
TABLE 40 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 41 NORTH AMERICA: MARKET FOR MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 42 EUROPE: MARKET FOR MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: MARKET FOR MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
7.6 SPECTROPHOTOMETRY
7.6.1 HIGH DEMAND FOR SPECTROPHOTOMETERS IN RESEARCH SETTINGS TO SUPPORT MARKET GROWTH
TABLE 44 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 45 NORTH AMERICA: MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 46 EUROPE: MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 47 ASIA PACIFIC: MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
7.7 HIGH-CONTENT SCREENING
7.7.1 HIGH DEMAND FOR HCS IN DRUG DISCOVERY TO SUPPORT SEGMENT GROWTH
TABLE 48 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 49 NORTH AMERICA: MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 50 EUROPE: MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 51 ASIA PACIFIC: MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
7.8 OTHER TECHNIQUES
TABLE 52 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 53 NORTH AMERICA: MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 54 EUROPE: MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 55 ASIA PACIFIC: MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021-2028 (USD MILLION)

8 CELL ANALYSIS MARKET, BY PROCESS (Page No. - 106)
8.1 INTRODUCTION
TABLE 56 CELL ANALYSIS INDUSTRY, BY PROCESS, 2021-2028 (USD MILLION)
8.2 CELL IDENTIFICATION
8.2.1 INCREASING RESEARCH ACTIVITIES TO PROPEL SEGMENT GROWTH
TABLE 57 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 58 NORTH AMERICA: MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 59 EUROPE: MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 60 ASIA PACIFIC: MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
8.3 CELL VIABILITY
8.3.1 USE OF CELL VIABILITY PROCESS TO CORRELATE CELL BEHAVIOR TO CELL NUMBERS
TABLE 61 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 62 NORTH AMERICA: MARKET FOR CELL VIABILITY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 63 EUROPE: MARKET FOR CELL VIABILITY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 64 ASIA PACIFIC: MARKET FOR CELL VIABILITY, BY COUNTRY, 2021-2028 (USD MILLION)
8.4 CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION
8.4.1 HIGH DEMAND FOR TOXICITY TESTING IN DRUG DEVELOPMENT TO DRIVE MARKET
TABLE 65 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 66 NORTH AMERICA: MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 67 EUROPE: MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
8.5 CELL PROLIFERATION
8.5.1 MEASUREMENT OF CELL PROLIFERATION BASED ON AVERAGE DNA CONTENT TO DRIVE SEGMENT
TABLE 69 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 70 NORTH AMERICA: MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 71 EUROPE: MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 72 ASIA PACIFIC: MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2021-2028 (USD MILLION)
8.6 CELL COUNTING AND QUALITY CONTROL
8.6.1 USE OF FLOW CYTOMETRY IN CELL COUNTING TO ENABLE EASY CELL DIFFERENTIATION VIA SCATTERING OR STAINING
TABLE 73 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 74 NORTH AMERICA: MARKET FOR CELL COUNTING AND QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 75 EUROPE: MARKET FOR CELL COUNTING AND QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 76 ASIA PACIFIC: MARKET FOR CELL COUNTING AND QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)
8.7 CELL INTERACTION
8.7.1 ADVANCEMENT IN CELL-CELL INTERACTIONS/COMMUNICATIONS TO BOOST MARKET GROWTH
TABLE 77 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 78 NORTH AMERICA: MARKET FOR CELL INTERACTION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 79 EUROPE: MARKET FOR CELL INTERACTION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: MARKET FOR CELL INTERACTION, BY COUNTRY, 2021-2028 (USD MILLION)
8.8 CELL STRUCTURE STUDY
8.8.1 ADVANCEMENTS IN CELLULAR IMAGING TO SUPPORT MARKET GROWTH
TABLE 81 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 82 NORTH AMERICA: MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 83 EUROPE: MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2021-2028 (USD MILLION)
8.9 TARGET IDENTIFICATION AND VALIDATION
8.9.1 ADOPTION OF HIGH-CONTENT SCREENING IN TARGET IDENTIFICATION TO DRIVE MARKET
TABLE 85 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 86 NORTH AMERICA: MARKET FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 87 EUROPE: MARKET FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: MARKET FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2021-2028 (USD MILLION)
8.1 SINGLE-CELL ANALYSIS
8.10.1 EXPANDING APPLICATIONS OF SINGLE-CELL ANALYSIS IN CLINICAL RESEARCH TO PROPEL SEGMENT GROWTH
TABLE 89 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 91 EUROPE: MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 92 ASIA PACIFIC: MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)

9 CELL ANALYSIS MARKET, BY END USER (Page No. - 131)
9.1 INTRODUCTION
TABLE 93 CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.2.1 HIGH DEMAND FOR CELL-BASED RESEARCH IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE SEGMENT
TABLE MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 95 NORTH AMERICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 96 EUROPE: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 97 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
9.3 HOSPITALS AND CLINICAL TESTING LABORATORIES
9.3.1 ADOPTION OF ADVANCED TECHNOLOGIES TO SUPPORT MARKET GROWTH
TABLE 98 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 99 NORTH AMERICA: MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 100 EUROPE: MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
9.4 ACADEMIC AND RESEARCH INSTITUTES
9.4.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET
TABLE 102 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 103 NORTH AMERICA: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 104 EUROPE: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
9.5 OTHER END USERS
TABLE 106 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 107 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 108 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 109 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 CELL ANALYSIS MARKET, BY REGION (Page No. - 143)
10.1 INTRODUCTION
TABLE 110 CELL ANALYSIS INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: CELL ANALYSIS MARKET SNAPSHOT
TABLE 111 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 112 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 113 NORTH AMERICA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 114 NORTH AMERICA: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 115 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.1 US
10.2.1.1 Rising prevalence of cancer to drive cell analysis demand in US
TABLE 116 US: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 117 US: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 118 US: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 119 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing government initiatives targeted toward stem cell research to drive market
TABLE 120 CANADA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 121 CANADA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 122 CANADA: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 123 CANADA: CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
10.3 EUROPE
TABLE 124 EUROPE: CELL ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 125 EUROPE: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 126 EUROPE: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 127 EUROPE: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 128 EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Strong R&D infrastructure, training, and awareness programs to drive market in Germany
TABLE 129 GERMANY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 130 GERMANY: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 131 GERMANY: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 132 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Presence of large biotechnology industry to boost market growth
TABLE 133 FRANCE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 134 FRANCE: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 135 FRANCE: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 136 FRANCE: CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
10.3.3 UK
10.3.3.1 Growing acceptance of flow cytometry products for clinical diagnostics to drive market
TABLE 137 UK: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 138 UK: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 139 UK: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 140 UK: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing research activities and conferences to support market growth
TABLE 141 ITALY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 142 ITALY: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 143 ITALY: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 144 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Strong focus on cancer diagnosis to boost flow cytometry product usage in Spain
TABLE 145 SPAIN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 146 SPAIN: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 147 SPAIN: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 148 SPAIN: CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 149 REST OF EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 150 REST OF EUROPE: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 151 REST OF EUROPE: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 152 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: CELL ANALYSIS MARKET SNAPSHOT
TABLE 153 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 154 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 155 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 156 ASIA PACIFIC: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 157 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Easy access to technologically advanced cell analysis products to favor market growth
TABLE 158 JAPAN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 159 JAPAN: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 160 JAPAN: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 161 JAPAN: CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Strategic partnerships in cell therapy sector to support market growth
TABLE 162 CHINA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 163 CHINA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 164 CHINA: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 165 CHINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Government initiatives to drive market in India
TABLE 166 INDIA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 167 INDIA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 168 INDIA: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 169 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 170 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 171 REST OF ASIA PACIFIC: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: CELL ANALYSIS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 GROWING PARTICIPATION OF ACADEMIC INSTITUTES IN RESEARCH TO ACCELERATE MARKET GROWTH
TABLE 174 LATIN AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 175 LATIN AMERICA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 176 LATIN AMERICA: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 177 LATIN AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING RESEARCH ACTIVITIES TO FUEL DEMAND FOR CELL ANALYSIS PRODUCTS
TABLE 178 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: MARKET, BY PROCESS, 2021-2028 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 192)
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 26 CELL ANALYSIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 MARKET SHARE ANALYSIS
FIGURE 27 CELL ANALYSIS INDUSTRY SHARE ANALYSIS (2022)
11.4 REVENUE SHARE ANALYSIS (TOP 7 MARKET PLAYERS)
FIGURE 28 REVENUE ANALYSIS FOR KEY COMPANIES, 2021-2022
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 29 CELL ANALYSIS INDUSTRY: COMPANY EVALUATION MATRIX, 2022
11.6 COMPETITIVE LEADERSHIP MAPPING FOR EMERGING COMPANIES/SMES/START-UPS (2022)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 30 CELL ANALYSIS INDUSTRY: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2022
11.7 COMPETITIVE SCENARIO AND TRENDS
11.7.1 PRODUCT LAUNCHES
TABLE 182 CELL ANALYSIS INDUSTRY: PRODUCT LAUNCHES
11.7.2 DEALS
TABLE 183 CELL ANALYSIS INDUSTRY: DEALS

12 COMPANY PROFILES (Page No. - 203)
12.1 KEY COMPANIES
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 184 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 31 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
TABLE 185 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
TABLE 186 THERMO FISHER SCIENTIFIC: PRODUCT LAUNCHES
TABLE 187 THERMO FISHER SCIENTIFIC INC.: DEALS
12.1.2 DANAHER
TABLE 188 DANAHER: COMPANY OVERVIEW
FIGURE 32 DANAHER: COMPANY SNAPSHOT (2022)
TABLE 189 DANAHER: PRODUCT OFFERINGS
TABLE 190 DANAHER: DEALS
TABLE 191 DANAHER: OTHER DEVELOPMENTS
12.1.3 BECTON, DICKINSON AND COMPANY (BD)
TABLE 192 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
FIGURE 33 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT (2022)
TABLE 193 BECTON, DICKINSON AND COMPANY (BD): PRODUCT OFFERINGS
TABLE 194 BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES
12.1.4 GENERAL ELECTRIC
TABLE 195 GENERAL ELECTRIC: COMPANY OVERVIEW
FIGURE 34 GENERAL ELECTRIC: COMPANY SNAPSHOT (2022)
TABLE 196 GENERAL ELECTRIC: PRODUCT OFFERINGS
12.1.5 MERCK KGAA
TABLE 197 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022)
TABLE 198 MERCK KGAA: PRODUCT OFFERINGS
12.1.6 AGILENT TECHNOLOGIES, INC.
TABLE 199 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
TABLE 200 AGILENT TECHNOLOGIES, INC.: PRODUCT OFFERINGS
TABLE 201 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
12.1.7 BIO-RAD LABORATORIES, INC.
TABLE 202 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
FIGURE 37 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
TABLE 203 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS
TABLE 204 BIO-RAD LABORATORIES, INC.: DEALS
12.1.8 STANDARD BIOTOOLS
TABLE 205 STANDARD BIOTOOLS: COMPANY OVERVIEW
FIGURE 38 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022)
TABLE 206 STANDARD BIOTOOLS: PRODUCT OFFERINGS
12.1.9 MILTENYI BIOTEC
TABLE 207 MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 208 MILTENYI BIOTEC: PRODUCT OFFERINGS
TABLE 209 MILTENYI BIOTEC: PRODUCT LAUNCHES
12.1.10 OLYMPUS CORPORATION
TABLE 210 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 39 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 211 OLYMPUS CORPORATION: PRODUCT OFFERINGS
12.1.11 BIOSTATUS LIMITED
TABLE 212 BIOSTATUS LIMITED: COMPANY OVERVIEW
TABLE 213 BIOSTATUS LIMITED: PRODUCT OFFERINGS
12.1.12 NANOCELLECT BIOMEDICAL
TABLE 214 NANOCELLECT BIOMEDICAL: BUSINESS OVERVIEW
TABLE 215 NANOCELLECT BIOMEDICAL: PRODUCT OFFERINGS
TABLE 216 NANOCELLECT BIOMEDICAL: DEALS
TABLE 217 NANOCELLECT BIOMEDICAL: PRODUCT LAUNCHES
12.1.13 CELL BIOLABS, INC.
TABLE 218 CELL BIOLABS, INC.: COMPANY OVERVIEW
TABLE 219 CELL BIOLABS, INC.: PRODUCT OFFERINGS
12.1.14 CREATIVE BIOARRAY
TABLE 220 CREATIVE BIOARRAY: COMPANY OVERVIEW
TABLE 221 CREATIVE BIOARRAY: SERVICE OFFERINGS
12.1.15 MEIJI TECHNO
TABLE 222 MEIJI TECHNO: COMPANY OVERVIEW
TABLE 223 MEIJI TECHNO: PRODUCT OFFERINGS
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 PROMEGA CORPORATION
TABLE 224 PROMEGA CORPORATION: COMPANY OVERVIEW
12.2.2 PERKINELMER U.S. LLC
TABLE 225 PERKINELMER: COMPANY OVERVIEW
12.2.3 TECAN TRADING AG
TABLE 226 TECAN TRADING AG: COMPANY OVERVIEW
12.2.4 CARL ZEISS AG
TABLE 227 CARL ZEISS AG: COMPANY OVERVIEW
12.2.5 SYSMEX
TABLE 228 SYSMEX: COMPANY OVERVIEW
12.2.6 CELLINK
TABLE 229 CELLINK: COMPANY OVERVIEW
12.2.7 QIAGEN
TABLE 230 QIAGEN: COMPANY OVERVIEW
12.2.8 ILLUMINA, INC.
TABLE 231 ILLUMINA, INC.: COMPANY OVERVIEW
12.2.9 CORNING INCORPORATED
TABLE 232 CORNING INCORPORATED: COMPANY OVERVIEW
12.2.10 10X GENOMICS
TABLE 233 10X GENOMICS: COMPANY OVERVIEW

13 APPENDIX (Page No. - 244)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS